How treatment works
Actor portrayals.
RYBREVANT FASPRO™ and RYBREVANT® are not chemotherapy—they are targeted treatments that work with chemotherapy to fight cancer
RYBREVANT FASPRO™ and RYBREVANT® each work against EGFR+ cancer in 2 ways:
Helps stop the activity cancer cells use to grow and spread
Chemotherapy is a key part of the treatment that stops cancer cells from dividing and growing.
Activates your immune system to help destroy cancer cells
Both RYBREVANT FASPRO™ and RYBREVANT® work well when used with chemotherapy, since they fight cancer in a different way than chemotherapy does.
RYBREVANT FASPRO™ and RYBREVANT® are both made of amivantamab, a targeted treatment that works against EGFR and MET receptors.
RYBREVANT FASPRO™ also includes hyaluronidase, which helps your body absorb the medication as an injection under your skin.
RYBREVANT FASPRO™ is not recommended for people who have had allergic reactions to hyaluronidase or any of its ingredients.
*Exon 19 deletion or exon 21 L858R substitution mutations.
Chemotherapy = carboplatin + pemetrexed
EGFR+, mutated epidermal growth factor receptor; MET, mesenchymal-epithelial transition; NSCLC, non–small cell lung cancer.
About side effects
Learn more about the side effects that you may experience during treatment with RYBREVANT FASPRO™ + chemotherapy or RYBREVANT® + chemotherapy.
Savings & support
Once prescribed RYBREVANT FASPRO™ or RYBREVANT®, connect with a Care Navigator for your support needs.